Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (997)	11/6/1998 4:40:00 PM
From: Anthony Wong	Respond to of 1722

Pfizer Inc. Reiterated 'Buy' at Gerard Klauer Bloomberg News November 6, 1998, 3:11 p.m. ET Princeton, New Jersey, Nov. 6 (Bloomberg Data) -- Pfizer Inc. (PFE US) was reiterated ''buy'' by analyst Cynthia A. Beach at Gerard Klauer Mattison & Co. The 12-month target price is $120.00 per share.

To: Anthony Wong who wrote (997)	11/6/1998 4:51:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

Prescriptions and worldwide sales of WLA's Lipitor vs MRK's Zocor: Nationally, doctors wrote about 19.5 million prescriptions for Lipitor in the 12 months ended Sept. 30, compared to 15.8 million for Zocor, according to National Health Information Services in Phoenix. In worldwide sales, Zocor has the lead, with $2.8 billion in sales for the first nine months of 1998, compared to $1.5 billion for Lipitor, according to the two companies. biz.yahoo.com

To: Anthony Wong who wrote (997)	11/8/1998 11:30:00 PM
From: Henry Niman	Read Replies (1) \| Respond to of 1722

I have linked the first part of a BBRS review of the AHA conference in the Cardiovascular Drugs table on the New Therapeutics page at biocognizance.com There is also a few interesting GILD links in the anti-HIV table (GILD's Preveon is effective against hepatitis B).